DC

Decheng Capital Portfolio holdings

AUM $396M
This Quarter Return
+23.46%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$396M
AUM Growth
+$396M
Cap. Flow
-$111M
Cap. Flow %
-27.91%
Top 10 Hldgs %
92.38%
Holding
28
New
1
Increased
3
Reduced
8
Closed
3

Top Buys

1
ACLX icon
Arcellx
ACLX
$4.05M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
$472K
3
RZLT icon
Rezolute
RZLT
$267K
4
KRYS icon
Krystal Biotech
KRYS
$137K

Top Sells

1
LYEL icon
Lyell Immunopharma
LYEL
$100M
2
CYTK icon
Cytokinetics
CYTK
$4.02M
3
RCUS icon
Arcus Biosciences
RCUS
$3.29M
4
LEGN icon
Legend Biotech
LEGN
$2.84M
5
BNTX icon
BioNTech
BNTX
$1.82M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CGON icon
1
CG Oncology
CGON
$2.04B
$166M 41.84%
6,371,669
– –
AARD
2
Aardvark Therapeutics, Inc. Common Stock
AARD
$180M
$53M 13.38%
3,917,299
– –
NUVB icon
3
Nuvation Bio
NUVB
$1.02B
$50.6M 12.78%
25,954,439
– –
UPB
4
Upstream Bio, Inc. Common Stock
UPB
$923M
$36.1M 9.11%
3,285,293
– –
NAMS icon
5
NewAmsterdam Pharma
NAMS
$2.71B
$13.9M 3.52%
770,000
– –
BYSI icon
6
BeyondSpring
BYSI
$69.4M
$10.6M 2.69%
4,531,481
-351,170
-7% -$825K
MRUS icon
7
Merus
MRUS
$4.98B
$9.95M 2.51%
189,098
– –
KRYS icon
8
Krystal Biotech
KRYS
$4.27B
$9.07M 2.29%
66,000
+1,000
+2% +$137K
MLTX icon
9
MoonLake Immunotherapeutics
MLTX
$3.54B
$8.57M 2.16%
181,600
+10,000
+6% +$472K
RVMD icon
10
Revolution Medicines
RVMD
$7.1B
$8.31M 2.1%
226,000
– –
ACRS icon
11
Aclaris Therapeutics
ACRS
$209M
$5.74M 1.45%
4,041,736
– –
LYEL icon
12
Lyell Immunopharma
LYEL
$213M
$5.26M 1.33%
595,466
-11,313,875
-95% -$100M
ACLX icon
13
Arcellx
ACLX
$3.85B
$4.46M 1.13%
547,609
+497,609
+995% +$4.05M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$2.92B
$4.11M 1.04%
143,000
-34,958
-20% -$1.01M
AURA icon
15
Aura Biosciences
AURA
$389M
$3.23M 0.82%
515,555
– –
ZNTL icon
16
Zentalis Pharmaceuticals
ZNTL
$122M
$1.54M 0.39%
1,323,327
-696,435
-34% -$808K
EQ icon
17
Equillium
EQ
$62.2M
$1.4M 0.35%
4,447,308
– –
FDMT icon
18
4D Molecular Therapeutics
FDMT
$288M
$889K 0.22%
239,510
-96,005
-29% -$356K
RCUS icon
19
Arcus Biosciences
RCUS
$1.13B
$811K 0.2%
160,000
-648,789
-80% -$3.29M
ILMN icon
20
Illumina
ILMN
$15.8B
$761K 0.19%
7,979
-3,770
-32% -$360K
LEGN icon
21
Legend Biotech
LEGN
$6.41B
$710K 0.18%
20,000
-80,000
-80% -$2.84M
GRAL
22
GRAIL, Inc. Common Stock
GRAL
$1.18B
$498K 0.13%
9,684
– –
PYXS icon
23
Pyxis Oncology
PYXS
$79.4M
$359K 0.09%
326,810
– –
RZLT icon
24
Rezolute
RZLT
$619M
$267K 0.07%
+59,900
New +$267K
NUVB.WS icon
25
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$127K 0.03%
646,057
– –
1
2